Skip to main content
Log in

LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Aim

This study aimed to demonstrate the role of serotonin 7 receptor (5-HT7) and the effects of 5-HT7 agonists and antagonists in an indomethacin-induced gastric ulcer.

Material and method

Male albino Wistar rats (n = 60) were used in the experiments. LP44 (5-HT7 agonist) and SB269970 (5-HT7 antagonist) were administered at 10 mg/kg as a pre-treatment. One hour after the drug treatments, 25 mg/kg of indomethacin (INDO) was administered to all groups except the healthy control group. Six hours after indomethacin administration, all the rats were euthanized.

Results

We analyzed the iNOS, eNOS, and 5-HT7 receptor mRNA levels in the stomach tissue of rats by real-time PCR. 5-HT7 mRNA expression was increased in the INDO group compared to the healthy group. LP44 administration exerted a significant upregulatory effect on eNOS mRNA expression and downregulatory effects on iNOS and 5-HT7 mRNA expression compared to the INDO group. However, antagonist (SB269970) administration did not result in such difference in gene expression, but even partially decreased the agonist’s effect in combination. Famotidine and agonist exerted similar effects. Histopathological findings supported the beneficial effects of 5-HT7 agonist on gastric tissue.

Conclusion

The study suggested that activation of 5-HT7 receptor showed a significant anti-ulcerogenic effect in the indomethacin-induced gastric ulcer model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AGO:

LP44 (5-HT7 agonist)

ANTA:

SB-269970 (5-HT7 antagonist)

COX-1:

Cyclooxygenase-1

COX-2:

Cyclooxygenase-2

DMSO:

Dimethyl sulfoxide

ECs:

Enterochromaffin cells

eNOS:

Endothelial nitric oxide synthase

FAM:

Famotidine

GIS:

Gastrointestinal system

GMI:

Gastric microscopic injury

GPCRs:

G-protein-coupled receptors

GU:

Gastric ulcer

H&E:

Hematoxylin–eosin

HP:

Helicobacter pylori

5-HT:

5-Hydroxytryptamine

5-HT7 :

5-Hydroxytryptamine 7 receptor

IL-1:

Interleukin-1

INDO:

Indomethacin

iNOS:

Inducible nitric oxide synthase

MAO-A:

Monoamine oxidase A

NO:

Nitric oxide

NSAIDs:

Non-steroidal anti-inflammatory drugs

PG:

Prostaglandin

PGE2 :

Prostaglandin E2

SD:

Standard deviation

SERT:

Serotonin reuptake transporter

TNFα:

Tumor necrosis factor alpha

References

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zekai Halici.

Ethics declarations

Conflict of interest

There is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calik, I., Yayla, M., Cinar, I. et al. LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats. Inflammopharmacol 28, 893–902 (2020). https://doi.org/10.1007/s10787-020-00725-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-020-00725-3

Keywords

Navigation